Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1151.5 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1151.5/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.5 |
Version | 20160713 |
Status | active |
Date | 2016-07-13T01:00:02-04:00 |
Name | BCGBacillusCalmetteGuerinConnaught |
Title | BCG Bacillus Calmette Guerin, Connaught |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: BCG is used for the treatment of non muscle invasive bladder cancer and is administered intravesically.),(Data Element Scope: The intent of this data element is to include BCG as a treatment for non muscle invasive bladder cancer),(Inclusion Criteria: Bacillus Calmette Guerin for intravesical use),(Exclusion Criteria: None) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
No narrative content found in resource
{ "resourceType": "ValueSet", "id": "2.16.840.1.113762.1.4.1151.5", "meta": { "versionId": "3", "lastUpdated": "2023-12-21T17:43:03.000-05:00", "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ] }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-author", "valueContactDetail": { "name": "Oregon Urology Author" } }, { "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate", "valueDate": "2024-02-08" }, { "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate", "valueDate": "2016-07-13" } ], "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.5", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113762.1.4.1151.5" } ], "version": "20160713", "name": "BCGBacillusCalmetteGuerinConnaught", "title": "BCG Bacillus Calmette Guerin, Connaught", "status": "active", "experimental": false, "date": "2016-07-13T01:00:02-04:00", "publisher": "Oregon Urology Steward", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "US" } ] } ], "purpose": "(Clinical Focus: BCG is used for the treatment of non muscle invasive bladder cancer and is administered intravesically.),(Data Element Scope: The intent of this data element is to include BCG as a treatment for non muscle invasive bladder cancer),(Inclusion Criteria: Bacillus Calmette Guerin for intravesical use),(Exclusion Criteria: None)", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "concept": [ { "code": "76469", "display": "BCG, Live, Connaught Strain" } ] } ] }, "expansion": { "identifier": "urn:uuid:4b6cc8cb-5911-4300-89ae-f0f3d83724e1", "timestamp": "2025-05-23T18:58:52-04:00", "total": 1, "contains": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "76469", "display": "BCG, live, Connaught strain" } ] } }